Toll-like receptors (TLRs) are pivotal in innate immunity and inflammation. Here we show that genetic deficiency in Peli1, an E3 ubiquitin ligase, attenuated the induction of proinflammatory cytokines by ligands of TLR3 and TLR4 and rendered mice resistant to septic shock. Peli1 was required for TLR3-induced activation of IB kinase (IKK) and its 'downstream' target, transcription factor NF-B, but was dispensable for IKK-NF-B activation induced by several other TLRs and the interleukin 1 (IL-1) receptor. Notably, Peli1 bound to and ubiquitinated RIP1, a signaling molecule that mediates IKK activation induced by the TLR3 and TLR4 adaptor TRIF. Our findings suggest that Peli1 is a ubiquitin ligase needed for the transmission of TRIF-dependent TLR signals.
Innate immunity serves as the first line of host defense against infection. Host cells are equipped with pattern-recognition receptors that recognize diverse pathogen-associated molecular patterns, such as lipopolysaccharide (LPS), peptidoglycan (PGN), single-and double-stranded RNA, and DNA 1 . A major family of pattern-recognition receptors is the Toll-like receptor (TLR) family. So far, ten human and twelve mouse TLRs, each of which recognizes distinct pathogen-associated molecular patterns, have been cloned 2 . For example, TLR4 recognizes LPS derived from the outer membrane of Gram-negative bacteria and TLR3 recognizes viral double-stranded RNA as well as the synthetic nucleic acid poly(I:C), whereas TLR9 recognizes unmethylated CpG motifs present in bacterial and viral DNA 2 . Recognition of pathogen-associated molecular patterns by TLRs triggers signaling pathways that lead to the production of proinflammatory cytokines, chemokines and type I interferons. These proteins combat invading pathogens and recruit additional cells of the immune response to the site of infection. TLRs also facilitate the induction of costimulatory molecules (for example, CD80 and CD86) and major histocompatibility complex (MHC) class II on dendritic cells and B cells, and stimulate B cell proliferation 3, 4 .
A key TLR signaling event is activation of the NF-κB family of transcription factors, which mediate the induction of various proinflammatory cytokines and many other genes involved in the immune response 2, 5 . In unstimulated cells, NF-κB proteins are sequestered in the cytoplasm by the inhibitory IκB proteins 5 . In response to TLR stimuli, IκB kinases (IKKs) phosphorylate IκB proteins, causing their degradation and nuclear translocation of NF-κB 5 . Another TLR signaling pathway stimulated by TLR3 and TLR4 involves activation of the IKK-related kinases IKKε (also called IKKi) and TBK1 (refs. 6,7) , which are responsible for the activation of interferon-regulatory factor 3 (IRF3), a transcription factor that mediates the induction of genes encoding type I interferons and interferon-regulatory factors 2 .
The signaling function of TLRs depends on intracellular adaptors 2 . The adaptor MyD88 transmits signals emanating from all TLRs, except TLR3, and from the interleukin 1 receptor (IL-1R). Another signaling adaptor, TRIF (also called TICAM1) (A004068), specifically mediates TLR3 and TLR4 signaling [8] [9] [10] . TLR4 is unique in that it induces both MyD88-and TRIF-dependent signaling pathways. MyD88-mediated signaling involves the recruitment and activation of IL-1R-associated kinases (IRAKs) 11 . After activation, IRAKs interact with and activate TRAF6, an E3 ubiquitin ligase that specifically catalyzes lysine 63 (K63)-linked ubiquitin chains 12 . TRAF6-mediated K63 ubiquitination is critical in transducing TLR-proximal signals to 'downstream' events, particularly the activation of IKK and NF-κB 13 .
Studies suggest that the function of IRAKs may also involve interaction with the Peli (also called Pellino) family of proteins 12 . Peli proteins are mammalian homologs of drosophila Peli, a molecule that interacts with the drosophila IRAK-like molecule Pelle 14 . Mammalian cells have three Peli members, which share strong sequence homology and contain a RING-like domain 12 . In vitro studies suggest that Peli proteins function as E3 ubiquitin ligases that catalyze K63-linked ubiquitin chains [15] [16] [17] . Like TRAF6, Peli proteins physically interact with IRAKs (IRAK1 and IRAK4) and induce ubiquitination of IRAK1 (refs. [15] [16] [17] . On the basis of cell line-transfection studies, Peli proteins have been linked to the regulation of IL-1R-and MyD88dependent TLR signaling 12 . However, so far, the physiological functions of Peli proteins have not been resolved.
Compared with knowledge about the MyD88-dependent signaling pathway, much less is known regarding how TRIF transduces TLR-proximal signals. Nevertheless, studies have established RIP1 as an essential adaptor that mediates IKK activation 'downstream' of TRIF-dependent TLR3 signals 18, 19 . RIP1 was originally identified as an adaptor kinase that transduces tumor necrosis factor (TNF) 1 0 9 0 VOLUME 10 NUMBER 10 OctOBER 2009 nature immunology A r t i c l e s receptor signals. In the TNF receptor pathway, the ubiquitin ligase TRAF2 interacts with and ubiquitinates RIP1, which in turn recruits IKK and its 'upstream' kinase, TAK1; these kinases are then activated 13 . RIP1 ubiquitination is also induced by the TLR3 ligand poly(I:C) and is required for poly(I:C)-stimulated IKK activation 18 . RIP1 interacts with TRIF through a RIP homotypic interaction motif 19 , and the TRIF-RIP1 signaling complex also contains the adaptor molecule TRADD [20] [21] [22] . Despite these important findings, the ubiquitin ligase responsible for ubiquitinating RIP1 in the TRIF-dependent TLR pathway has remained elusive. Although TRAF6 has been proposed to ubiquitinate RIP1, TRAF6-knockout studies have demonstrated a dispensable role for this E3 ubiquitin ligase in TRIF-dependent IKK activation 23 .
Here we provide genetic evidence that Peli1 has a nonredundant role in regulating RIP1 ubiquitination and IKK activation in the TRIFdependent TLR pathway. Peli1 deficiency caused a specific defect in the induction of proinflammatory genes by ligands of TLR3 and TLR4 and rendered mice resistant to LPS-and poly(I:C)-induced death. Peli1 physically interacted with RIP1 and induced RIP1 ubiquitination. Loss of Peli1 attenuated TLR3-stimulated RIP1 ubiquitination and IKK activation but had no effect on the activation of IKK-related kinases. These findings suggest that Peli1 is an E3 ubiquitin ligase that mediates IKK-NF-κB activation in the TRIF-dependent TLR signaling pathway.
RESULTS

Normal lymphocyte development in Peli1 -/mice
To understand the physiological function of Peli1 in immune regulation, we studied Peli1 -/mice. We generated these mutant mice by a conventional targeting strategy in which coding exons 1 and 2 were replaced with a lacZ-neomycin-resistance cassette (Supplementary Fig. 1) . The homozygous Peli1-knockout (Peli1 -/-) mice were viable and did not show overt abnormalities in growth and survival. The development of thymocytes seemed to be normal, as Peli1 -/and Peli1 +/+ mice produced similar frequencies of CD4 + and CD8 + single-positive cells and CD4 + CD8 + double-positive cells ( Supplementary Fig. 2 ). The number of T cells was also normal in the spleens of Peli1 -/mice (data not shown). Similarly, the Peli1 deficiency did not cause an obvious defect in the generation of B cells. Follicular and marginal zone B cells were present in similar percentages in Peli1 -/and Peli1 +/+ mice (Supplementary Fig. 2 ). Thus, Peli1 seems to be dispensable for the development of cells of the immune response.
Septic shock resistance of Peli1 -/mice
To investigate the in vivo function of Peli1 in regulating TLR signaling, we used a septic shock model involving intraperitoneal injection of the TLR4 ligand LPS plus a liver-specific transcription inhibitor, D-galactosamine, which enhances the toxicity of LPS 24 . In this acute inflammation model, death occurs within hours and is dependent mainly on production of the proinflammatory cytokine TNF 25, 26 . As expected, injection of LPS and D-galactosamine caused death of most Peli1 +/+ mice within 9 h and killed all of them within 18 h ( Fig. 1a) . In contrast, none of the Peli1 -/mice succumbed to the induction of septic shock during the entire 24-hour time period ( Fig. 1a) . We also used a septic shock model that involved the injection of high doses of LPS in the absence of D-galactosamine. As expected, a much higher dose of LPS (45 mg per kg body weight) and a considerably longer time (24 h) were required to induce a moderate frequency of death in wild-type mice (two of six mice; Supplementary  Fig. 3 ). At this time, none of the Peli1 -/mice succumbed. After longer times, one of six Peli1 -/mice died, compared with 50% of the Peli1 +/+ mice (Supplementary Fig. 3 ). Thus, although the results were less striking than those in the acute lethality model, Peli1 deficiency also diminished the lethality of the high-dose LPS model.
Like LPS, the TLR3 ligand poly(I:C) also induces death in mice by a TNF-dependent mechanism 27 . We thus examined the effect of Peli1 deficiency on the death induced by poly(I:C). In contrast to LPS, poly(I:C) was relatively inefficient in inducing death. Nevertheless, at a high dose (0.5 µg per g body weight), poly(I:C) induced death of most of the Peli1 +/+ mice within 8 h but of none of the Peli1 -/mice at this early time point ( Fig. 1b) . Even at late times, only one of six Peli1 -/mice died.
To understand the molecular mechanism mediating the resistance of Peli1 -/mice to septic shock induction, we obtained blood from LPS-and poly(I:C)-challenged mice during early time periods (1-4 h) after injection of LPS and poly(I:C) and measured the serum concentrations of proinflammatory cytokines as well as the antiviral cytokine interferon-β (IFN-β). Injection of Peli1 +/+ mice led to the production of high concentrations of TNF, IL-6, IL-12p40 and IFN-β ( Fig. 1c) . Consistent with the lethality results, the induction of proinflammatory cytokines was severely attenuated in Peli1 -/mice ( Fig. 1c) . Loss of Peli1 also partially inhibited the induction of proinflammatory cytokines by poly(I:C) ( Fig. 1d) . In contrast, Peli1 deficiency resulted in only slightly lower production of IFN-β ( Fig. 1c,d) . These results suggest a critical role for Peli1 in regulating TLR3-and TLR4mediated induction of proinflammatory cytokines and death.
Next we analyzed the effect of Peli1 deficiency on TLR-mediated gene induction in vitro. For these studies, we prepared primary mouse embryonic fibroblasts (MEFs) from Peli1 +/+ and Peli1 -/littermate embryos (dissected from the same pregnant females). Stimulation of Peli1 +/+ MEFs by LPS and poly(I:C) led to the induction of Tnf expression ( Fig. 2a) . Consistent with the in vivo studies, induction of Tnf by both LPS and poly(I:C) was severely inhibited in Peli1 -/-MEFs. Peli1 was also essential for LPS-and poly(I:C)-stimulated expression of the gene encoding another proinflammatory molecule, IL-12p40 (Il12b; Fig. 2a ). However, Peli1 is not a universal signaling component of the TLR pathway, as it was not required for LPS-and poly(I:C)-stimulated expression of the gene encoding IFN-β (Ifnb1) and an interferon-responsive gene, Cxcl10, which encodes the interferon-inducible protein IP-10 (ref. 28 ; Fig. 2a ).
Real-time PCR analysis and enzyme-linked immunosorbent assay (ELISA) of bone marrow-derived macrophages showed that Peli1 was critical for Il12b induction by LPS and poly(I:C) and was partially required for Il12b induction by CpG (Fig. 2b,c) . In addition, in bone marrow-derived dendritic cells and B cells, poly(I:C)stimulated proinflammatory gene expression was severely attenuated in the absence of Peli1 ( Fig. 2d,e ). However, Peli1 deficiency did not appreciably affect gene induction by several other TLR ligands, including Pam 3 CSK 4 (TLR1-TLR2), R-837 (TLR7 and TLR8) and MALP-2 (TLR2-TLR6; Supplementary Fig. 4 ). Thus, Peli1 is required for the induction of genes encoding proinflammatory cytokines mainly by LPS and poly(I:C).
Peli1 in TLR-mediated B cell activation and survival
TLRs is important in B cell activation [29] [30] [31] . In response to TLR signals, B cells express costimulatory molecules and increase their expression of MHC class II molecules, thus enhancing their ability to activate helper T cells. To determine whether Peli1 is involved in TLR-mediated B cell activation, we analyzed the effect of Peli1 deficiency on the activation of B cells derived from Peli1 +/+ and Peli1 -/mice. As expected, stimulation of Peli1 +/+ B cells with several TLR ligands (LPS, poly(I:C), PGN and CpG) led to potent induction of the costimulatory molecule CD86 and enhanced expression of MHC class II ( Fig. 3a) . We also detected induction of these molecules in cells stimulated with antibodies that crosslink immunoglobulin M (IgM) and the costimulatory molecule CD40 (Fig. 3a) . Induction of both CD86 and MHC class II by LPS was attenuated in Peli1 -/-B cells (Fig. 3a) . The inhibitory effect of Peli1 deficiency on the induction of CD86 and MHC class II was even more profoundly evident in B cells stimulated with the TLR3 ligand poly(I:C) ( Fig. 3a) . In contrast, loss of Peli1 had no effect on the induction of CD86 and MHC class II by several other TLR ligands, including PGN and CpG ( Fig. 3a) , as well as Pam 3 CSK 4 , MALP-2 and R-837 ( Supplementary Fig. 5 and data not shown). Furthermore, Peli1 was dispensable for the induction of CD86 and MHC class II by antibody to IgM (anti-IgM) and anti-CD40. Thus, Peli1 is required for the induction of CD86 and MHC class II specifically by TLR3 and TLR4 signals. TLR signals also induce the proliferation of B cells 31 . Consistent with that, proliferation of Peli1 +/+ B cells was stimulated by a panel of TLR ligands as well as by crosslinking of IgM or CD40 (Fig. 3b) . As seen with the induction of expression of CD86 and MHC class II, the induction of proliferation by LPS and poly(I:C) was severely inhibited in Peli1 -/-B cells. This effect was again more profound for poly(I:C). We detected partial inhibition of CpG-and Pam 3 (Fig. 3b) . This effect, however, was not general for all MyD88-binding TLRs, as loss of Peli1 did not inhibit the induction of B cell proliferation by R-837, MALP-2 or PGN ( Fig. 3b) . Peli1 deficiency did not affect proliferation induced by crosslinking of IgM or CD40. In fact, we repeatedly detected enhanced proliferation of PGN-and anti-CD40-stimulated Peli1 -/-B cells, although it is unclear at present how Peli1 negatively regulates the signaling of these pathways.
TLR ligands, particularly LPS and CpG 32, 33 , also stimulate the survival of B cells. To examine the function of Peli1 in TLR-driven survival, we incubated Peli1 +/+ and Peli1 -/-B cells in vitro in the presence and absence of various TLR ligands. In the absence of TLR ligands, Peli1 +/+ B cells underwent massive apoptosis, as determined by staining with annexin V and propidium iodide. After culture for 24 h, less than 20% of the cells were negative for both propidium iodide and annexin V (Fig. 3c) , but the spontaneous death of Peli1 +/+ B cells was greatly inhibited by LPS and CpG and was moderately inhibited by several other TLR ligands ( Fig. 3c) . However, loss of Peli1 severely attenuated the prosurvival effects of LPS, poly(I:C), and CpG ( Fig. 3c) . Thus, Peli1 mediates TLR3-and TLR4-driven induction of costimulatory gene expression, proliferation and survival in B cells.
Peli1 in IKK-NF-B activation
A central signaling event of TLR-mediated gene induction is activation of IKK and its 'downstream' transcription factor, NF-κB 2 . To investigate the function of Peli1 in this process, we examined the effect of Peli1 deficiency on TLR-stimulated activation of IKK and NF-κB in various cell types. Consistent with the results of the gene-induction studies ( Figs. 2 and 3) , poly(I:C)-stimulated NF-κB activation was severely attenuated in Peli1 -/-MEFs (Fig. 4a) . Peli1-deficient MEFs also showed a partial inhibition of NF-κB activation by LPS (Fig. 4a) . Parallel kinase assays showed that Peli1 deficiency largely impaired the poly(I:C)-stimulated activation of IKK and also partially inhibited the LPS-stimulated activation of IKK (Fig. 4b) . As TLR4 activates IKK through both MyD88-and TRIF-dependent pathways, whereas TLR3 activates IKK exclusively through TRIF 2 , these results suggest that Peli1 serves a nonredundant function in promoting IKK activation in the TRIF-dependent TLR pathway.
We next examined the function of Peli1 in the activation of NF-κB in B cells. As seen in MEFs, Peli1 deficiency markedly inhibited poly(I:C)-stimulated activation of NF-κB ( Fig. 4c) and IKK (Fig. 4d) . Loss of Peli1 also partially inhibited LPS-stimulated NF-κB activation. However, Peli1 was largely dispensable for NF-κB activation by CpG and anti-IgM (Fig. 4c) . We obtained a similar result with splenocytes, in which Peli1 was required for IKK activation by poly(I:C) but not by other TLR ligands (Fig. 4e) . Notably, the effect of Peli1 deficiency on LPS-stimulated IKK activation was not appreciable in splenocytes. These results further suggest a role for Peli1 in mediating activation of IKK-NF-κB by the TRIF-dependent TLRs, particularly TLR3.
In addition to activating IKK, the TRIF-dependent TLR pathway stimulates activity of the IKK-related kinases IKKε and TBK1. To further investigate the signaling mechanism of Peli1, we examined its role in the activation of IKKε induced by poly(I:C) and LPS. In contrast to the activation of IKK, the activation of IKKε 'downstream' of both poly(I:C) and LPS was similar in Peli1 -/and Peli1 +/+ MEFs (Fig. 4f) . Thus, Peli1 serves a selective function in regulating IKK-NF-κB activation by TLR3.
Peli1 is dispensable for IL-1R signaling
Published transfection studies with a cell-line model suggest that Peli1 facilitates IL-1R signaling 34 . However, it is unknown whether Peli1 is required for IL-1R signaling in physiological conditions. To address this, we examined the effect of Peli1 deficiency on IL-1R-mediated induction of proinflammatory genes in primary MEFs, a cell type that responds efficiently to IL-1β stimulation. In Peli1 +/+ MEFs, IL-1β stimulated the expression of Tnf and Il6, although it did not induce appreciable expression of Il12b (Fig. 5a and data not shown) . IL-1β also induced expression of Cxcl10, the gene that encodes IP-10, in Peli1 +/+ MEFs. However, loss of Peli1 did not affect IL-1β-stimulated expression of Tnf, Il6 or Cxcl10 (Fig. 5a) . To further examine the function of Peli1 in IL-1R signaling, we used an in vivo geneinduction model. When injected into Peli1 +/+ mice, IL-1β stimulated the production of high concentrations of IL-6 ( Fig. 5b) , although it did not induce detectable quantities of TNF (data not shown). Consistent with the in vitro results, Peli1 was completely dispensable for IL-1β-induced production of IL-6 in vivo (Fig. 5b) .
To directly examine the function of Peli1 in IL-1R signaling, we analyzed the effect of Peli1 deficiency on IL-1β-stimuated activation of NF-κB and IKK. IL-1β stimulated similar NF-κB DNAbinding activity in Peli1 +/+ and Peli1 -/-MEFs (Fig. 5c) . Consistent with that, loss of Peli1 did not affect IL-1β-stimulated activation of IKK (Fig. 5d ). Together these results suggest that Peli1 is either functionally redundant with other Peli proteins or not critical in the IL-1R signaling pathway. As IL-1R transduces signals through MyD88 (ref. 35 ), these results are consistent with the dispensable function of Peli1 in IKK-NF-κB activation by the MyD88-dependent TLR2 and TLR9 (Fig. 4c,e ).
Peli1 induces RIP1 ubiquitination
The signaling studies presented above suggested a function for Peli1 in regulating IKK activation in the TRIF-dependent TLR pathway. A hallmark of this pathway of IKK activation is ubiquitination of the TRIF-interacting adaptor kinase RIP1 (ref. 18) . In response to poly(I:C) stimulation, RIP1 undergoes K63 ubiquitination, which is critical for the recruitment and activation of IKK. So far, the ubiquitin ligase of RIP1 in the TRIF-dependent TLR pathway has remained unidentified. As Peli1 is an E3 ubiquitin ligase [15] [16] [17] that is critical for IKK activation by TLR3, we examined the potential function of Peli1 in ubiquitinating RIP1. We first analyzed whether Peli1 is essential for poly(I:C)-stimulated ubiquitination of RIP1. Consistent with published studies 18, 21 , stimulation of Peli1 +/+ MEFs with poly(I:C) led to the accumulation of ubiquitinated RIP1 (Fig. 6a) . In contrast, poly(I:C)-stimulated RIP1 ubiquitination was largely blocked in the Peli1 -/cells ( Fig. 6a and Supplementary Fig. 6) .
We next examined whether Peli1 physically associates with RIP1. When expressed together in 293 cells, Peli1 and RIP1 indeed formed a stable complex that was readily detected by coimmunoprecipitation assay (Fig. 6b) . Peli1 also interacted with endogenous RIP1 (Fig. 6c) . Peli1-RIP1 binding seemed to be further enhanced by expression of TRIF, and Peli1 seemed to enhance the association between TRIF and endogenous RIP1 (Fig. 6c) . These enhanced physical interaction activities were not due to an increase in the expression of RIP1, TRIF or Peli1 (Fig. 6c) . As Peli1 was essential for poly(I:C)-stimulated RIP1 ubiquitination, we examined whether Peli1 was able to induce RIP1 ubiquitination. Indeed, when expressed together with Peli1, RIP1 became potently ubiquitinated (Fig. 6d,e) . Moreover, the Peli1mediated RIP1 ubiquitination was further enhanced by TRIF (Fig. 6d) . Peli1-mediated RIP1 ubiquitination required the RING domain of Peli1, as the ubiquitination of RIP1 was not induced by Peli1 mutants with RING deletion or point substitutions (Fig. 6f) . Peli1-mediated RIP1 ubiquitination seemed to be direct, as Peli1 also induced RIP1 ubiquitination in a cell-free system (Fig. 6g,h) . These results suggest that Peli1 is an E3 ubiquitin ligase that mediates RIP1 ubiquitination in the TRIF-dependent TLR pathway.
DISCUSSION
Peli proteins have a K63 ubiquitin ligase function [15] [16] [17] , although their physiological role has remained unknown. The results presented here have demonstrated a critical function for Peli1 in facilitating TLR3stimulated activation of IKK and its 'downstream' transcription factor, NF-κB. Peli1 interacted with the TRIF-signaling adaptor kinase A r t i c l e s RIP1 and mediated RIP1 ubiquitination, a key step in the TRIFdependent IKK-signaling pathway. Consequently, Peli1 was required for TLR3-stimulated expression of proinflammatory cytokines and B cell activation. Peli1 was also important for TLR4-mediated gene induction, although it was only partially required for LPS-stimulated activation of IKK and NF-κB. This result is reminiscent of the phenotype of TRIF-and RIP1-deficient cells and can be attributed to the involvement of both TRIF-and MyD88-dependent pathways in TLR4mediated IKK-NF-κB activation 10, 18, 33 . Our study has further shown that like RIP1, Peli1 was dispensable for IKK-NF-κB activation induced by IL-1R and the MyD88-dependent TLR2 and TLR9.
Peli1 joins TRAF6 as the second E3 ubiquitin ligase known to mediate IKK-NF-κB activation in the TLR-signaling pathways. However, these two E3 molecules seem to have distinct functions. Extensive studies have established TRAF6 as an essential E3 ubiquitin ligase in the MyD88-dependent TLR and IL-1R signaling pathways 2 . In contrast, TRAF6 seems to be less important for TRIF-dependent TLR signaling. Although TRAF6 binds to TRIF and modulates TRIFspecific signaling function in transfection conditions 36 , TRAF6 deficiency does not impair poly(I:C)-stimulated NF-κB activation 23 . In contrast to TRAF6, Peli1 is critical for TRIF-dependent TLR signaling but is dispensable for the signaling function of MyD88dependent TLRs and IL-1R. The finding that Peli1 was not required for IL-1R signaling is unexpected, as a published transfection study has suggested a function for Peli1 in regulating IL-1R signaling in 293 human embryonic kidney cells 34 . It is unclear at present whether Peli1 is functionally redundant with TRAF6 or other Peli members in mediating the signaling of IL-1R and MyD88-dependent TLRs. As the different Peli family members share strong sequence homology 12 , it is possible that they have functional redundancy in certain signaling pathways and cell types. Nevertheless, our findings suggest a crucial function for Peli1 in the TRIF-dependent NF-κB signaling pathway. It is important to note, however, that the defect of Peli1 -/mice and cells in cytokine induction was less severe than that of TRIF-deficient mice and cells. This finding indicates that Peli1 homologs or additional E3 proteins may also participate in TRIF signaling. An alternative explanation is that the ubiquitination of RIP1 is important but not absolutely essential for mediating TRIF-dependent NF-κB activation.
The signaling function of Peli1 seems to be cell type specific, with the most obvious phenotype in B cells and MEFs. Future studies should examine whether the cell type-specific function of Peli1 is due to its expression amount or redundancy with other Peli members.
The TRIF-dependent TLR3 signaling pathway activates IKKε and TBK1, which mediate activation of IRF3 and interferon-responsive genes. Like the activation of IKK, the activation of IKKε and TBK1 also involves K63 ubiquitination. We have shown that Peli1 deficiency had only moderate effects on LPS-and poly(I:C)-induced expression of type I interferons both in vivo and in vitro. Furthermore, Peli1 was not required for TLR3-mediated activation of IKKε. Consistent with our findings, TRAF3 has been suggested to be the E3 ubiquitin ligase that mediates activation of IKKε and TBK1 (ref. 37) . Our finding that Peli1 regulated RIP1 further suggests a specific function for Peli1 in the IKK-NF-κB signaling axis, as RIP1 mediates activation of NF-κB but not of IRF3 (ref. 18) . When injected in vivo, poly(I:C) also induces a cytoplasmic pattern-recognition receptor signaling pathway involving the adaptors Mda5 and IPS-1 (also known as MAVS and Cardif) 38, 39 . Future studies should examine whether Peli1 has a role in regulating the Mda5-IPS-1 signaling pathway.
Our data suggest that in addition to its role in regulating the signaling function of TRIF-dependent TLRs (TLR3 and TLR4), Peli1 is partially required for B cell proliferation and survival stimulated by CpG (TLR9 ligand) and Pam 3 CSK 4 (TLR1-TLR2 ligand). However, this function is not general for all MyD88-dependent TLRs, because Peli1 is not required for B cell activation induced by the ligands of TLR2 (PGN), TLR2-TLR6 (MALP-2) or TLR7-TLR8 (R-837). It is unclear at present how Peli1 regulates the function of specific MyD88-dependent TLRs, but circumstantial evidence suggests the involvement of RIP1 in some MyD88-dependent TLRs, particularly TLR9. Like Peli1 -/-B cells, RIP1-deficient B cells are partially defective in CpG-induced B cell proliferation 33 . As Peli1 is not required for CpG-stimulated NF-κB activation, we propose that Peli1 might regulate CpG-mediated activation of other signaling factors or specific members of NF-κB.
Additional signaling functions of Peli1 are also indicated by the interaction of Peli proteins with IRAK family members, particularly IRAK1 and IRAK4 (ref. 12) . Whether IRAKs are involved in the signaling function of Peli1 in the TLR3 signaling pathway remains to be investigated. However, this possibility is less likely, as IRAKs do not seem to have a critical role in TRIF-dependent TLR signaling, despite their critical participation in the MyD88-dependent TLR and IL-1R signaling pathways [40] [41] [42] . It is more likely that IRAKs modulate the function of Peli1 in MyD88-dependent TLR and IL-1R pathways. As discussed above, this function of Peli1 might be masked by its functional redundancy with other Peli members or TRAF6. The generation of mouse models deficient in different Peli proteins is important for addressing this issue. Notwithstanding those caveats, our work here has established that Peli1 is an E3 ubiquitin ligase that is specifically required for TRIF-induced RIP1 ubiquitination and IKK activation.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
ONLINE METHODS
Mice. Peli1-knockout mice (C57BL/6 × 129/sv genetic background) were from the Texas Institute for Genomic Medicine. Mice were generated by a conventional gene-targeting strategy in which coding exons 1 and 2 were replaced with a lacZ-neomycin-resistance cassette ( Supplementary  Fig. 1a ). Mice were genotyped by PCR analysis of DNA obtained from tail tissue (primers, Supplementary Methods). Mice were maintained in the specific pathogen-free facility of The University of Texas MD Anderson Cancer Center. Peli1 +/mice were bred to generate age-and sex-matched Peli1 -/and Peli1 +/+ mice, which were used in the experiments. All animal experiments were in accordance with protocols approved by the Institutional Animal Care and Use Committee of the University of Texas MD Anderson Cancer Center.
Plasmids, antibodies and reagents. The plasmid pcDNA-HA-Peli1 was constructed by isolation of mouse Peli1 cDNA (by PCR) from macrophage RNA and was cloned into the pcDNA vector with a 5′ hemagglutinin tag. E-tag-fused Peli1, as well as a mutant lacking its carboxy-terminal RING domain and a mutant bearing a double point substitution (H369S,C371S) in the RING domain, were cloned into the pCAGGS vector and were provided by R. Beyaert 15 . The plasmids pCMV14-3xFlag-TRIF, pCMV10-3XFlag-RIP1 and pcDNA3-myc-RIP1 were provided by M.K. Offermann and W.J. Kaiser 43 .
The plasmid pcDNA-HA-ubiquitin and GST-IκBα have been described 44, 45 .
GST Cell culture, transfection and stimulation. The human embryonic kidney cell line 293T was cultured in DMEM containing 5% (vol/vol) FBS. Cells were seeded in six-well plates and were transfected by the calcium phosphate method. For the preparation of Peli1 +/+ and Peli1 -/primary MEFs, Peli1 +/mice were bred to produce Peli1 +/+ and Peli1 -/embryos. Cells were prepared from embryos dissected from the same pregnant female at day 13.5 and were cultured in DMEM supplemented with 10% (vol/vol) FBS. Splenocytes were prepared with nylon mesh followed by lysis of red blood cells. Before stimulation, cells were allowed to 'rest' for 3 h in RPMI medium supplemented with 2% (vol/vol) FCS. B cells were purified from the splenocyte samples with anti-B220-conjugated magnetic beads (Miltenyl Biotec). For proliferation and survival assays, cells were stimulated with various agents in four replicate wells at a density of 1 × 10 5 cells per well in 96-well plates for proliferation analysis or 1 × 10 6 cells per well in 24-well plates for survival analysis. Bone marrow-derived macrophages and dendritic cells were prepared from the femurs of mice as described 46, 47 . Cells were 'starved' overnight in DMEM supplemented with 0.5% (vol/vol) FCS before being stimulated by TLR ligands.
Flow cytometry. Splenic and thymic cell suspensions were analyzed by flow cytometry as described 48 with an LSR II.
B cell proliferation and apoptosis assay. After stimulation, B cells were labeled for 6 h with [ 3 H]thymidine. Apoptosis was analyzed by staining of cells with fluorescein isothiocyanate-labeled annexin V and propidium iodide, followed by flow cytometry 49 .
Immunoblot, immunoprecipitation, kinase assay and in vivo ubiquitination assay. Whole-cell lysates were prepared in a kinase cell-lysis buffer supplemented with phosphatase inhibitors and were subjected to immunoblot analysis, coimmunoprecipitation and in vitro kinase assays as described 45 . For ubiquitination assays, cells were lysed in radioimmunoprecipitation assay buffer supplemented with 1 mM N-ethylmaleimide. Lysates were immediately heated for 5 min in the presence of 1% (wt/vol) SDS and then were diluted ten times with radioimmunoprecipitation assay buffer. Ubiquitinated RIP1 was isolated by immunoprecipitation and was detected by immunoblot analysis with anti-ubiquitin or anti-hemagglutinin (3F10).
In vitro ubiquitination assay. Myc-tagged RIP1 was translated in vitro with the wheat-germ system in the presence of [ 35 S]methionine according to the manufacturer's instructions (Promega). Hemagglutinin-tagged Peli1 was translated in vitro with the rabbit reticulocyte lysate sytem in the absence of [ 35 S]methionine (Promega). 35 S-labeled RIP1 was subjected to in vitro ubiquitination assay in the presence or absence of Peli1. Ubiquitination reactions were done in 20 µl of reaction buffer (50 mM Tris-HCl, pH 7.5, 5 mM MgCl 2 and 2 mM ATP) containing 10 µg histidine-tagged ubiquitin, 100 ng ubiquitin-activating enzyme E1 and 500 ng ubiquitin-conjugating enzyme E2 (Ubc13-Uev1a complex; BostonBiochem), as well as in vitro-translated 35 S-labeled RIP1, in the presence or absence of Peli1. After 2 h of incubation at 30 °C, reactions were terminated by boiling for 5 min in SDS sample buffer. Ubiquitinated RIP1 was separated by SDS-PAGE, followed by autoradiography or immunoblot analysis.
EMSA.
Nuclear extracts were prepared and subjected to EMSA with a 32 P-radiolabeled κB oligonucleotide probe (5′-CAACGGCAGGGGAATTCC CCTCTCCTT-3′) or a control probe bound by NF-Y (5′-AAGAGATTAACC AATCACGTACGGTCT-3′).
Statistical analysis.
A two-tailed unpaired t-test was done with the Prism software. P values of less than 0.05 and 0.01 were considered significant and very significant, respectively.
